Clinical Trials Directory

Trials / Completed

CompletedNCT03878615

Inflammation and Organ Impact During Hepatic Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Sahlgrenska University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Monitoring of inflammatory substances (such as interleukins, CRP, albumine), and markers of organ dysfunction (such as creatinine, proenkephaline, amylase, troponine, IFABP and lactate) during elective liver resection. The study also includes monitoring of hemodynamic parameters, blood loss and postoperative complications. Results are to be used för power calculation for future trials.

Detailed description

During hepatic surgery, blood and urine samples will be obtained at 3 times during surgery, at 3 h after resection of liver, at 24 h after resection of liver and at post operative day 2, and subsequntly analyzed for the above mentioned substances. Routine labs will be monitored until patient is discharged from hospital. During surgery, hemodynamic parameters will be monitored by Picco calculations. Urine output and blood loss will be registred.

Conditions

Interventions

TypeNameDescription
PROCEDUREelective surgery, according to deprtement routinenone, descriptive study

Timeline

Start date
2018-11-10
Primary completion
2019-04-02
Completion
2019-04-02
First posted
2019-03-18
Last updated
2025-04-27

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT03878615. Inclusion in this directory is not an endorsement.